JP2001178489A - Method of producing cyclic phosphatidic acid - Google Patents

Method of producing cyclic phosphatidic acid

Info

Publication number
JP2001178489A
JP2001178489A JP36703299A JP36703299A JP2001178489A JP 2001178489 A JP2001178489 A JP 2001178489A JP 36703299 A JP36703299 A JP 36703299A JP 36703299 A JP36703299 A JP 36703299A JP 2001178489 A JP2001178489 A JP 2001178489A
Authority
JP
Japan
Prior art keywords
phosphatidic acid
cyclic phosphatidic
phospholipase
reaction
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP36703299A
Other languages
Japanese (ja)
Inventor
Kimiko Murofushi
きみ子 室伏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP36703299A priority Critical patent/JP2001178489A/en
Publication of JP2001178489A publication Critical patent/JP2001178489A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an enzymatic production process for cyclic phosphatidic acid. SOLUTION: In this production process for cyclic phosphatidic acid(cPA), a phospholipase D is allowed to react with the lysophospholipid. According to this invention, cyclic phosphatidic acid that is useful as a medicine or a phy.siologically active substance can be obtained simply in high yield.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は環状ホスファチジン
酸の製造法に関する。より詳細には、環状ホスファチジ
ン酸の酵素的製造法に関する。
The present invention relates to a method for producing cyclic phosphatidic acid. More specifically, the present invention relates to a method for enzymatic production of cyclic phosphatidic acid.

【0002】[0002]

【従来の技術】環状ホスファチジン酸(以下、cPAと
いうこともある)は、抗腫瘍剤としての用途が期待され
るグリセロリン脂質を有効成分とし腫瘍転移阻害効果を
有する(Int. J. Cancer: 81, 918-922, 1999) 。また、
環状ホスファチジン酸は、将来、機能性食品などを含む
新しい生理活性物質として期待されている。このような
環状ホスファチジン酸は、従来、化学的合成法によって
調製されている(特開平5-230088号公報、特開平7-1497
72号公報、特開平7-258278号公報、特開平9-25235号公
報など参照)。
2. Description of the Related Art Cyclic phosphatidic acid (hereinafter, also referred to as cPA) contains glycerophospholipid expected to be used as an antitumor agent as an active ingredient and has a tumor metastasis inhibitory effect (Int. J. Cancer: 81 , 918-922, 1999). Also,
Cyclic phosphatidic acid is expected as a new bioactive substance including functional foods in the future. Such a cyclic phosphatidic acid has been conventionally prepared by a chemical synthesis method (JP-A-5-230088, JP-A-7-1497).
No. 72, JP-A-7-258278, JP-A-9-25235, etc.).

【0003】[0003]

【発明が解決しようとする課題】上述のように、環状ホ
スファチジン酸は化学的合成法で製造されてきたが、環
状ホスファチジン酸は不安定であるので、化学的合成法
では高収率で目的物を得ることが困難であるという問題
があった。係る従来技術の問題点に鑑み、本発明者は環
状ホスファチジン酸の製造法について鋭意検討した結
果、ホスホリパーゼDが環状ホスファチジン酸を効率よ
く生成することを見出した。即ち、ホスホリパーゼD
(ホスファチジルコリンホスファチドヒドラーゼ、EC3.
1.4.4)はリン脂質に作用し、リン酸と塩基部分のエス
テル結合を加水分解し、また係る単なる加水分解の他に
ホスファチジル基をOH基へ転移する反応(ホスファチジ
ル基転移反応)をも触媒することが知られている。しか
し、ホスホリパーゼDを用いた環状ホスファチジン酸の
製造法は従来知られていなかった。本発明は係る知見に
基づいてなされたもので、本発明は環状ホスファチジン
酸を簡便且つ高収率で製造することができる方法を提供
することを目的とする。
As described above, cyclic phosphatidic acid has been produced by a chemical synthesis method, but cyclic phosphatidic acid is unstable. Is difficult to obtain. In view of the problems of the related art, the present inventors have conducted intensive studies on a method for producing cyclic phosphatidic acid, and as a result, have found that phospholipase D efficiently produces cyclic phosphatidic acid. That is, phospholipase D
(Phosphatidylcholine phosphatide hydrolase, EC3.
1.4.4) acts on phospholipids, hydrolyzes the ester bond between phosphoric acid and the base moiety, and catalyzes the phosphatidyl group transfer reaction (phosphatidyl group transfer reaction) in addition to the simple hydrolysis. It is known to However, a method for producing cyclic phosphatidic acid using phospholipase D has not been conventionally known. The present invention has been made based on such findings, and an object of the present invention is to provide a method capable of producing cyclic phosphatidic acid easily and with high yield.

【0004】[0004]

【課題を解決するための手段】上記の課題を解決するた
めになされた、本発明の要旨は、リゾ型リン脂質にホス
ホリパーゼDを作用させることからなる環状ホスファチ
ジン酸の製造法である。
The gist of the present invention, which has been made to solve the above-mentioned problems, is a method for producing cyclic phosphatidic acid, which comprises causing phospholipase D to act on lyso-type phospholipids.

【0005】[0005]

【発明の実施の形態】上述のように、本発明はリゾ型リ
ン脂質にホスホリパーゼDを作用させることからなる環
状ホスファチジン酸の製造法である。本発明で使用され
るリゾ型リン脂質はホスホリパーゼDが作用し得るリゾ
型リン脂質であれば特に限定されない。リゾ型リン脂質
は既に多種多様のものが知られており、脂肪酸種の異な
るもの、エーテル又はビニルエーテル結合をもった分子
種などが知られており、これらは市販品としても入手可
能である。
BEST MODE FOR CARRYING OUT THE INVENTION As described above, the present invention is a method for producing cyclic phosphatidic acid, which comprises reacting phospholipase D with a lyso-type phospholipid. The lyso-type phospholipid used in the present invention is not particularly limited as long as it is a lyso-type phospholipid on which phospholipase D can act. A wide variety of lyso-type phospholipids are already known, and those having different fatty acid species, molecular species having an ether or vinyl ether bond, and the like are known, and these are also available as commercial products.

【0006】ホスホリパーゼDは、反応基質としてのリ
ゾ型リン脂質に作用し、二種類の生成物、即ちリゾホス
ファチジン酸と環状ホスファチジン酸が産生される。図
1に、リゾホスファチジルコリンの例を示す。図に示さ
れるように、リゾホスファチジルコリン(LPC)にホス
ホリパーゼDを作用させると、リン酸とコリンとのエス
テル結合が加水分解されてリゾホスファチジン酸(LP
A)が生成する反応と、ホスファチジル基の転移反応に
より環状ホスファチジン酸(cPA)が生成する反応が起
こる。後者の反応により、リゾ型リン脂質より環状ホス
ファチジン酸が得られる。
[0006] Phospholipase D acts on lyso-type phospholipids as reaction substrates to produce two types of products, lysophosphatidic acid and cyclic phosphatidic acid. FIG. 1 shows an example of lysophosphatidylcholine. As shown in the figure, when phospholipase D acts on lysophosphatidylcholine (LPC), the ester bond between phosphoric acid and choline is hydrolyzed, and lysophosphatidic acid (LP) is hydrolyzed.
A reaction that generates A) and a reaction that generates cyclic phosphatidic acid (cPA) by a phosphatidyl group transfer reaction occur. By the latter reaction, cyclic phosphatidic acid is obtained from the lyso-type phospholipid.

【0007】上記の反応で使用されるホスホリパーゼD
としては、キャベツや落花生などの高等植物由来のもの
やStreptomyces chromofuscusなどの微生物由来のもの
が利用でき、これらは市販試薬として入手可能である。
しかし、加水分解反応とホスファチジル基転移反応の相
対的な強弱は各々の酵素で異なる。本発明においては、
特にActinomadura sp. Strain No.362由来のホスホリパ
ーゼDを使用するのが好ましく、リゾ型リン脂質に作用
させることにより様々な環状ホスファチジン酸類似体を
効率よく調製できることを見出している。
The phospholipase D used in the above reaction
As such, those derived from higher plants such as cabbage and peanuts and those derived from microorganisms such as Streptomyces chromofuscus can be used, and these can be obtained as commercial reagents.
However, the relative strengths of the hydrolysis reaction and the phosphatidyl transfer reaction are different for each enzyme. In the present invention,
In particular, phospholipase D derived from Actinomadura sp. Strain No. 362 is preferably used, and it has been found that various cyclic phosphatidic acid analogs can be efficiently prepared by acting on lyso-type phospholipid.

【0008】リゾ型リン脂質とホスホリパーゼDとの反
応は、酵素が活性を発現できる条件であれば特に限定さ
れないが、例えば、塩化カルシウムを含有する酢酸緩衝
液(pH5‐6程度)中で、室温〜加温下(好ましくは37℃
程度)で、1〜5時間程度反応させることにより行われ
る。生成した環状ホスファチジン酸は、常法に準じて、
抽出、カラムクロマトグラフィー、薄層クロマトグラフ
ィー(TLC)などにより精製することができる。
[0008] The reaction between the lyso-type phospholipid and phospholipase D is not particularly limited as long as the enzyme can exhibit its activity. For example, the reaction is performed in an acetate buffer containing calcium chloride (about pH 5-6) at room temperature. ~ Under heating (preferably 37 ° C
About 1-5 hours). The generated cyclic phosphatidic acid is prepared according to a conventional method.
It can be purified by extraction, column chromatography, thin layer chromatography (TLC) and the like.

【0009】かくして調製された環状ホスファチジン酸
は、医薬品あるいは種々の産業に利用することができ
る。特に、腫瘍転移阻害活性を有することから、新しい
抗腫瘍剤として期待される。また、環状ホスファチジン
酸は、将来、機能性食品などを含む新しい生理活性物質
として期待されている。
[0009] The cyclic phosphatidic acid thus prepared can be used for pharmaceuticals or various industries. In particular, since it has a tumor metastasis inhibitory activity, it is expected as a new antitumor agent. In addition, cyclic phosphatidic acid is expected as a new physiologically active substance including functional foods in the future.

【0010】[0010]

【発明の効果】本発明においては、ホスホリパーゼDと
リゾ型リン脂質を反応させることにより、環状ホスファ
チジン酸を簡便にして効率よく得ることができる。しか
も、リン脂質は多種多様であるが、何れののリゾ型リン
脂質であってもホスホリパーゼDを作用させることによ
り、それに対応した構造をもつ環状ホスファチジン酸を
調製することが可能である。環状ホスファチジン酸は有
機合成では不安定で調製しづらく、特にビニールエーテ
ル結合をもったプラズマローゲン型の環状ホスファチジ
ン酸は有機合成では調製困難であるが、酵素法では容易
に調製できる利点がある。
According to the present invention, cyclic phosphatidic acid can be easily and efficiently obtained by reacting phospholipase D with lyso-type phospholipid. In addition, there are various types of phospholipids, and it is possible to prepare a cyclic phosphatidic acid having a corresponding structure by acting phospholipase D on any lyso-type phospholipid. Cyclic phosphatidic acid is unstable in organic synthesis and is difficult to prepare. In particular, plasmalogen type cyclic phosphatidic acid having a vinyl ether bond is difficult to prepare in organic synthesis, but has an advantage that it can be easily prepared by an enzymatic method.

【0011】[0011]

【実施例】以下、実施例に基づいて、本発明をより詳細
に説明するが、本発明はこれらの例に限定されるもので
はない。 実施例1 リゾホスファチジルコリン(LPC) 約50μmoleに、反応溶
媒として10mM塩化カルシウムを含む100mM酢酸緩衝液(pH
5.6) 50mlを加え、超音波洗浄器中でLPCを懸濁させる。
得られた懸濁液にホスホリパーゼD酵素溶液0.5mlを添
加してよく混合した後、37℃で振とうしながら2時間反
応させる。なお、ホスホリパーゼD酵素溶液は、ホスホ
リパーゼD(Actinomadura sp.Strain No.362由来、名
糖産業(株)製造、生化学工業(株)発売)100unitを
蒸留水1mlに溶解したものを使用した。
EXAMPLES Hereinafter, the present invention will be described in more detail based on examples, but the present invention is not limited to these examples. Example 1 Lysophosphatidylcholine (LPC) 100 mM acetate buffer (pH: 10 mM) containing about 50 μmole and 10 mM calcium chloride as a reaction solvent
5.6) Add 50 ml and suspend the LPC in the ultrasonic cleaner.
After adding 0.5 ml of a phospholipase D enzyme solution to the obtained suspension and mixing well, the mixture is reacted at 37 ° C. with shaking for 2 hours. The phospholipase D enzyme solution used was prepared by dissolving 100 units of phospholipase D (derived from Actinomadura sp. Strain No. 362, manufactured by Meito Sangyo Co., Ltd., and released by Seikagaku Corporation) in 1 ml of distilled water.

【0012】次いで、反応が進行していることを薄層ク
ロマトグラフィー(TLC)で確認した後、反応液中に1Mク
エン酸水溶液を1.7ml加えて反応の終了とする。なお、T
LCは、TLC(Silica Gel 60)を用いて、展開溶媒 クロロ
ホルム:メタノール:酢酸:5%二亜硫酸ナトリウム水溶
液(100:40:12:5, 容量比)で展開した。LPCのRf値は約0.
1, 環状ホスファチジン酸のRf値は約0.5である。少量の
副産物としてできるLPAのRf値は約0.3である。
Next, after the progress of the reaction is confirmed by thin layer chromatography (TLC), 1.7 ml of a 1 M aqueous citric acid solution is added to the reaction solution to terminate the reaction. Note that T
LC was developed using TLC (Silica Gel 60) with a developing solvent of chloroform: methanol: acetic acid: 5% aqueous sodium disulfite solution (100: 40: 12: 5, volume ratio). The Rf value of LPC is about 0.
1, The Rf value of cyclic phosphatidic acid is about 0.5. The Rf value of LPA, which is formed as a small by-product, is about 0.3.

【0013】反応終了後、反応液を氷冷し、クロロホル
ム:メタノール(2:1)の混合液を26ml加える。よく撹拌
した後に、1,400xgで、5分間遠心し、メタノール水層
(上層)とクロロホルム(下層)とに分離する。下層の
クロロホルム層のみを別の容器に移し、残されたメタノ
ールー水層にも再度、クロロホルム:メタノール(2:1)
混合液を260ml加える。先程と同様に遠心を行った後、
下層のクロロホルム層を分取し、先のクロロホルム層と
合わせる。これをロータリーエバポレーターで濃縮し、
残った液体に少量のベンゼンを加えて、窒素気流下で完
全に乾固させることにより環状ホスファチジン酸を得
た。かくして得られた環状ホスファチジン酸はクロロホ
ルム:メタノール(1:1)の溶液数mlに溶解し、-20℃以下
で保存した。
After the completion of the reaction, the reaction solution is ice-cooled and 26 ml of a mixed solution of chloroform: methanol (2: 1) is added. After stirring well, centrifuge at 1,400 xg for 5 minutes to separate the aqueous methanol layer (upper layer) and chloroform (lower layer). Transfer only the lower chloroform layer to another container, and re-add the remaining methanol-water layer with chloroform: methanol (2: 1)
Add 260 ml of the mixture. After centrifugation as before,
The lower chloroform layer is separated and combined with the previous chloroform layer. This is concentrated on a rotary evaporator,
A small amount of benzene was added to the remaining liquid and completely dried under a nitrogen stream to obtain cyclic phosphatidic acid. The cyclic phosphatidic acid thus obtained was dissolved in a few ml of a chloroform: methanol (1: 1) solution and stored at -20 ° C or lower.

【0014】得られた環状ホスファチジン酸は41μmole
で、収率は約82%である。純度は約85-90%であり、必要
に応じて副産物のLPAや出発物質のLPCを調製用TLCやケ
イ酸カラムクロマトグラフィーを用いて除くことができ
る。
The cyclic phosphatidic acid thus obtained was 41 μmole
And the yield is about 82%. The purity is about 85-90%, and LPA as a by-product and LPC as a starting material can be removed using TLC for preparation or silica column chromatography as necessary.

【図面の簡単な説明】[Brief description of the drawings]

【図1】リゾホスファチジルコリン(LPC)とホスホリ
パーゼDとの反応を示す図である。
FIG. 1 shows the reaction between lysophosphatidylcholine (LPC) and phospholipase D.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 リゾ型リン脂質にホスホリパーゼDを
作用させることからなる環状ホスファチジン酸の製造
法。
1. A method for producing cyclic phosphatidic acid, which comprises reacting phospholipase D with a lyso-type phospholipid.
JP36703299A 1999-12-24 1999-12-24 Method of producing cyclic phosphatidic acid Pending JP2001178489A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP36703299A JP2001178489A (en) 1999-12-24 1999-12-24 Method of producing cyclic phosphatidic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36703299A JP2001178489A (en) 1999-12-24 1999-12-24 Method of producing cyclic phosphatidic acid

Publications (1)

Publication Number Publication Date
JP2001178489A true JP2001178489A (en) 2001-07-03

Family

ID=18488300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36703299A Pending JP2001178489A (en) 1999-12-24 1999-12-24 Method of producing cyclic phosphatidic acid

Country Status (1)

Country Link
JP (1) JP2001178489A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081580A1 (en) 2006-12-28 2008-07-10 Ochanomizu University Analgesic agent comprising cyclic phosphatidic acid derivative
JP2011211921A (en) * 2010-03-31 2011-10-27 Sansho Kk Method for producing cyclic phosphatidic acid
WO2011152519A1 (en) 2010-06-04 2011-12-08 学校法人帝京大学 Detection method
JP2013013404A (en) * 2011-06-07 2013-01-24 Sansho Kk Method for producing cyclic sodium phosphatidic acid and composition
WO2013069404A1 (en) 2011-11-11 2013-05-16 Sansho株式会社 Therapeutic agent for joint diseases
WO2014115885A1 (en) 2013-01-28 2014-07-31 国立大学法人お茶の水女子大学 Therapeutic agent for demyelinating disease
WO2019117187A1 (en) 2017-12-12 2019-06-20 Sansho株式会社 Method for preparing sodium cyclic phosphatidic acid
WO2022114058A1 (en) 2020-11-26 2022-06-02 Sansho株式会社 Therapeutic agent for pulmonary fibrosis

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63123389A (en) * 1986-11-14 1988-05-27 Meito Sangyo Kk Production of phospholipid-d-serine derivative by enzymatic method
JPH022381A (en) * 1988-03-30 1990-01-08 Kanegafuchi Chem Ind Co Ltd Production of phospholipid
JPH07149772A (en) * 1993-11-26 1995-06-13 Sagami Chem Res Center Activity promoter of protein phosphorylated enzyme c
JPH07258278A (en) * 1994-03-18 1995-10-09 Sagami Chem Res Center Dna polymerase alpha inhibitor containing 1-o-acylglycerol-2,3-phosphate derivative as active ingredient
JPH0925235A (en) * 1995-07-13 1997-01-28 Sagami Chem Res Center Suppressant for cancer metastasis containing 1-o-acylglycerol 2,3-phosphate derivative as active ingredient

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63123389A (en) * 1986-11-14 1988-05-27 Meito Sangyo Kk Production of phospholipid-d-serine derivative by enzymatic method
JPH022381A (en) * 1988-03-30 1990-01-08 Kanegafuchi Chem Ind Co Ltd Production of phospholipid
JPH07149772A (en) * 1993-11-26 1995-06-13 Sagami Chem Res Center Activity promoter of protein phosphorylated enzyme c
JPH07258278A (en) * 1994-03-18 1995-10-09 Sagami Chem Res Center Dna polymerase alpha inhibitor containing 1-o-acylglycerol-2,3-phosphate derivative as active ingredient
JPH0925235A (en) * 1995-07-13 1997-01-28 Sagami Chem Res Center Suppressant for cancer metastasis containing 1-o-acylglycerol 2,3-phosphate derivative as active ingredient

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017597B2 (en) 2006-12-28 2011-09-13 Ochanomizu University Analgesic agent comprising cyclic phosphatidic acid derivative
WO2008081580A1 (en) 2006-12-28 2008-07-10 Ochanomizu University Analgesic agent comprising cyclic phosphatidic acid derivative
JP2011211921A (en) * 2010-03-31 2011-10-27 Sansho Kk Method for producing cyclic phosphatidic acid
US9134330B2 (en) * 2010-06-04 2015-09-15 Teikyo University Detection method
WO2011152519A1 (en) 2010-06-04 2011-12-08 学校法人帝京大学 Detection method
JP2013013404A (en) * 2011-06-07 2013-01-24 Sansho Kk Method for producing cyclic sodium phosphatidic acid and composition
KR20130010102A (en) * 2011-06-07 2013-01-25 산쇼가부시키가이샤 Process for preparing sodium cyclic phosphatidic acid and composition comprising the same
JP2016183167A (en) * 2011-06-07 2016-10-20 Sansho株式会社 Preparation method for sodium cyclic phosphatidic acid and composition
KR101973593B1 (en) * 2011-06-07 2019-04-29 산쇼가부시키가이샤 Process for Preparing Sodium Cyclic Phosphatidic Acid and Composition Comprising the Same
WO2013069404A1 (en) 2011-11-11 2013-05-16 Sansho株式会社 Therapeutic agent for joint diseases
WO2014115885A1 (en) 2013-01-28 2014-07-31 国立大学法人お茶の水女子大学 Therapeutic agent for demyelinating disease
WO2019117187A1 (en) 2017-12-12 2019-06-20 Sansho株式会社 Method for preparing sodium cyclic phosphatidic acid
KR20200101939A (en) 2017-12-12 2020-08-28 산쇼가부시키가이샤 Method for producing sodium cyclic phosphatidate
CN111788312A (en) * 2017-12-12 2020-10-16 山椒株式会社 Process for producing cyclic sodium phosphatidate
JPWO2019117187A1 (en) * 2017-12-12 2020-12-03 Sansho株式会社 Method for Producing Cyclic Sodium Phosphatidate
JP7222551B2 (en) 2017-12-12 2023-02-15 Sansho株式会社 Method for producing cyclic sodium phosphatidate
CN111788312B (en) * 2017-12-12 2024-02-27 山椒株式会社 Method for producing cyclic sodium phosphatidate
WO2022114058A1 (en) 2020-11-26 2022-06-02 Sansho株式会社 Therapeutic agent for pulmonary fibrosis

Similar Documents

Publication Publication Date Title
STOFFEL et al. Biosynthesis and composition of phosphatides in outer and inner mitochondrial membranes
EP0940409B1 (en) Process for the preparation of sphingolipids and sphingolipid derivatives
JP2001178489A (en) Method of producing cyclic phosphatidic acid
Carman et al. Modification of the Agranoff‐Suomi method for the synthesis of CDP‐diacylglycerol
US6660504B2 (en) Process for exchanging bases in phospholipids
US4916249A (en) Glycero-3(2)-phospho-L-serine derivatives and salts thereof
Paltauf et al. [12] Preparation of alkyl ether and vinyl ether substrates for phospholipases
JPS6336792A (en) Production of phospholipid by enzyme
JPH0387191A (en) Production of phosphatidylinositol
AU3602700A (en) Improved method for the conversion of lecithin into lysolecithin
JPH0279990A (en) Production of phosphatidylserine
JP2657274B2 (en) Method for producing phospholipid
JP2011211921A (en) Method for producing cyclic phosphatidic acid
Rukavishnikov et al. Synthesis of a new fluorogenic substrate for the continuous assay of mammalian phosphoinositide-specific phospholipase C
JPS63123389A (en) Production of phospholipid-d-serine derivative by enzymatic method
JPS6188886A (en) Preparation of phospholipid long-chain alcohol derivative by enzymatic process
JP2731852B2 (en) A new method for producing lysophosphatidylcholine.
JP2683590B2 (en) Method for producing enzyme-converted phospholipid
JPH0751588B2 (en) Glycero-3 (2) -phospho-L-serine derivative or salt thereof and pharmaceutical preparation containing the same
Sato et al. Asymmetric in vitro synthesis of diastereomeric phosphatidylglycerols from phosphatidylcholine and glycerol by bacterial phospholipase D
KR101973593B1 (en) Process for Preparing Sodium Cyclic Phosphatidic Acid and Composition Comprising the Same
Aurich et al. Production of octadecylphospho-L-serine by phospholipase D
KUME et al. The Study on Phosphatidylinositol-Specific Phospholipase C from Bacillus thuringiensis: Synthesis of Homogeneous Substrates, Substrate Specificity and Other Properties
JP2009022220A (en) Method for producing ceramides
JP2003169692A (en) Method for producing phospholipid derivative or its salt

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061113

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091028

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100319

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100823